Regulation of hepatic oval cell proliferation by adenoviral mediated hepatocyte growth factor gene transfer and signal transduction inhibitors.

Hiroyuki Kato(University of North Carolina at Chapel Hill), Goshi Shiota(Regenerative Medicine Institute), Kazue Gonda(Tottori University), Rie Murai(Tottori University), Koichi Hashiguchi, Takashi Shimomura, Tomohiko Sakabe, Yoko Yoshida(Tottori University), Kazue Takubo, Akihiro Kurimasa(Tohoku Medical and Pharmaceutical University Hospital), Hiroyuki Tsuchiya(Kanazawa University), Kyoko Ishii(Tohoku University), Takamasa Kanbe, Yoshiko Hoshikawa(Tottori University), Jun‐ichi Okano(Shizuoka Saiseikai General Hospital)
PubMed
August 15, 2007
Cited by 8

Related Papers

Retinoic acid receptor α dominant negative form causes steatohepatitis and liver tumors in transgenic mice
|Hepatology|2004|139
Hepatic differentiation of human bone marrow–derived mesenchymal stem cells by tetracycline‐regulated hepatocyte nuclear factor 3β†
|Hepatology|2008|90
CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line
|Cancer Medicine|2019|73
miR‐181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of <scp>RASSF</scp>1 expression
|Cancer Science|2016|65
BH‐protocadherin‐c, a member of the cadherin superfamily, interacts with protein phosphatase 1 alpha through its intracellular domain
|FEBS Letters|1999|62